WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at two upcoming conferences in September.
At the Morgan Stanley 18th Annual Virtual Global Healthcare Conference:
|
Date: |
Monday, September 14, 2020 |
|
Time: |
3:00 p.m. Eastern Time |
Webcast: https://morganstanley.webcasts.com/starthere.jsp?ei=1362588&tp_key=91c8ad632b
At the Cantor Virtual Global Healthcare Conference:
|
Date: |
Tuesday, September 15, 2020 |
|
Time: |
10:00 a.m. Eastern Time |
Webcast: https://www.webcaster4.com/Webcast/Page/2495/37184
The presentations will be webcast live at the aforementioned times, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors + News Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200908005348/en/
Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M. Wilson
T: 212-452-2793
E: lwilson@insitecony.com
Source: Eagle Pharmaceuticals, Inc.